OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Anti-inflammatory effects of probiotics and synbiotics on patients with non-alcoholic fatty liver disease: An umbrella study on meta-analyses
Abinash Mahapatro, Fnu Bawna, Vikash Kumar, et al.
Clinical Nutrition ESPEN (2023) Vol. 57, pp. 475-486
Closed Access | Times Cited: 15
Abinash Mahapatro, Fnu Bawna, Vikash Kumar, et al.
Clinical Nutrition ESPEN (2023) Vol. 57, pp. 475-486
Closed Access | Times Cited: 15
Showing 15 citing articles:
Global prevalence of nonalcoholic fatty liver disease: an updated meta-analysis on 78 million population over 38 countries
Ehsan Amini‐Salehi, Negin Letafatkar, Naeim Norouzi, et al.
Archives of Medical Research (2024) Vol. 55, Iss. 6, pp. 103043-103043
Closed Access | Times Cited: 22
Ehsan Amini‐Salehi, Negin Letafatkar, Naeim Norouzi, et al.
Archives of Medical Research (2024) Vol. 55, Iss. 6, pp. 103043-103043
Closed Access | Times Cited: 22
The effects of gut microbiome manipulation on glycemic indices in patients with non-alcoholic fatty liver disease: a comprehensive umbrella review
Azin Vakilpour, Ehsan Amini‐Salehi, Arman Soltani Moghadam, et al.
Nutrition and Diabetes (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 8
Azin Vakilpour, Ehsan Amini‐Salehi, Arman Soltani Moghadam, et al.
Nutrition and Diabetes (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 8
Can modulation of gut microbiota affect anthropometric indices in patients with non-alcoholic fatty liver disease? An umbrella meta-analysis of randomized controlled trials
Ehsan Amini‐Salehi, Sandeep Samethadka Nayak, Gautam Maddineni, et al.
Annals of Medicine and Surgery (2024) Vol. 86, Iss. 5, pp. 2900-2910
Open Access | Times Cited: 7
Ehsan Amini‐Salehi, Sandeep Samethadka Nayak, Gautam Maddineni, et al.
Annals of Medicine and Surgery (2024) Vol. 86, Iss. 5, pp. 2900-2910
Open Access | Times Cited: 7
Role of gut microbiota and immune cells in metabolic-associated fatty liver disease: clinical impact
Anna Alisi, Geoffrey W. McCaughan, Henning Grønbæk
Hepatology International (2024) Vol. 18, Iss. S2, pp. 861-872
Closed Access | Times Cited: 7
Anna Alisi, Geoffrey W. McCaughan, Henning Grønbæk
Hepatology International (2024) Vol. 18, Iss. S2, pp. 861-872
Closed Access | Times Cited: 7
Exploring the relationship between gut microbiome modulation and blood pressure in type 2 diabetes: An umbrella review
Ehsan Amini‐Salehi, Abinash Mahapatro, Rohan Reddy Korsapati, et al.
Nutrition Metabolism and Cardiovascular Diseases (2024) Vol. 34, Iss. 9, pp. 2046-2054
Closed Access | Times Cited: 6
Ehsan Amini‐Salehi, Abinash Mahapatro, Rohan Reddy Korsapati, et al.
Nutrition Metabolism and Cardiovascular Diseases (2024) Vol. 34, Iss. 9, pp. 2046-2054
Closed Access | Times Cited: 6
Gut microbiota interventions in type 2 diabetes mellitus: An umbrella review of glycemic indices
Mohammad-Hossein Keivanlou, Ehsan Amini‐Salehi, Nazila Sattari, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2024) Vol. 18, Iss. 8, pp. 103110-103110
Closed Access | Times Cited: 5
Mohammad-Hossein Keivanlou, Ehsan Amini‐Salehi, Nazila Sattari, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2024) Vol. 18, Iss. 8, pp. 103110-103110
Closed Access | Times Cited: 5
An umbrella review of meta-analyses on the effects of microbial therapy in metabolic dysfunction-associated steatotic liver disease
Yuanyue Yao, Qing Hong, Siqi Ding, et al.
Clinical Nutrition (2025) Vol. 47, pp. 1-13
Closed Access
Yuanyue Yao, Qing Hong, Siqi Ding, et al.
Clinical Nutrition (2025) Vol. 47, pp. 1-13
Closed Access
Exploring public interest in gut microbiome dysbiosis, NAFLD, and probiotics using Google Trends
Salvatore Pezzino, Maria Sofia, Chiara Mazzone, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4
Salvatore Pezzino, Maria Sofia, Chiara Mazzone, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4
Revolutionizing lung health: Exploring the latest breakthroughs and future prospects of synbiotic nanostructures in lung diseases
Ayeh Bani Saeid, Gabriele De Rubis, Kylie A. Williams, et al.
Chemico-Biological Interactions (2024) Vol. 395, pp. 111009-111009
Open Access | Times Cited: 4
Ayeh Bani Saeid, Gabriele De Rubis, Kylie A. Williams, et al.
Chemico-Biological Interactions (2024) Vol. 395, pp. 111009-111009
Open Access | Times Cited: 4
The Association Between Systemic Immune-Inflammation Index and Cardiovascular Diseases: An In-depth Umbrella Review of Meta-Analyses with Grade Assessment
Ehsan Amini‐Salehi, Nimra Shafi, Rafael Contreras, et al.
Heliyon (2025), pp. e42736-e42736
Open Access
Ehsan Amini‐Salehi, Nimra Shafi, Rafael Contreras, et al.
Heliyon (2025), pp. e42736-e42736
Open Access
The association between neutrophil and lymphocyte to high-density lipoprotein cholesterol ratio and metabolic syndrome among Iranian population, finding from Bandare Kong cohort study
Seyyed Mohammad Hassan Hashemi, Masoumeh Kheirandish, Shideh Rafati, et al.
Lipids in Health and Disease (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 3
Seyyed Mohammad Hassan Hashemi, Masoumeh Kheirandish, Shideh Rafati, et al.
Lipids in Health and Disease (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 3
The effects of Lactobacillus plantarum PS128 in patients with major depressive disorder: an eight-week double-blind, placebo-controlled study
Shih-Kai Lin, Po‐Hsiu Kuo, Chia‐Yueh Hsu, et al.
Asian Journal of Psychiatry (2024) Vol. 101, pp. 104210-104210
Closed Access | Times Cited: 1
Shih-Kai Lin, Po‐Hsiu Kuo, Chia‐Yueh Hsu, et al.
Asian Journal of Psychiatry (2024) Vol. 101, pp. 104210-104210
Closed Access | Times Cited: 1
The role of gut microbiota augmentation in managing non-alcoholic fatty liver disease: an in-depth umbrella review of meta-analyses with grade assessment
Gautam Maddineni, Sri J. Obulareddy, Ruchir Paladiya, et al.
Annals of Medicine and Surgery (2024) Vol. 86, Iss. 8, pp. 4714-4731
Open Access
Gautam Maddineni, Sri J. Obulareddy, Ruchir Paladiya, et al.
Annals of Medicine and Surgery (2024) Vol. 86, Iss. 8, pp. 4714-4731
Open Access
Meta-analysis of randomized controlled trials of the effects of synbiotics, probiotics, or prebiotics in controlling glucose homeostasis in non-alcoholic fatty liver disease patients
Siqi Ding, Qing Hong, Yuanyue Yao, et al.
Food & Function (2024) Vol. 15, Iss. 19, pp. 9954-9971
Closed Access
Siqi Ding, Qing Hong, Yuanyue Yao, et al.
Food & Function (2024) Vol. 15, Iss. 19, pp. 9954-9971
Closed Access
The role of probiotics in the treatment of Non-Alcoholic Fatty Liver Disease (NAFLD): new insights based on meta-analysis and subgroup analysis
M. Xiao, Yang Cao, Linlin Wang, et al.
Food Bioscience (2024) Vol. 62, pp. 105454-105454
Closed Access
M. Xiao, Yang Cao, Linlin Wang, et al.
Food Bioscience (2024) Vol. 62, pp. 105454-105454
Closed Access
